dc.date.accessioned | 2024-02-20T18:13:26Z | |
dc.date.available | 2024-02-20T18:13:26Z | |
dc.date.created | 2023-11-10T13:20:33Z | |
dc.date.issued | 2023 | |
dc.identifier.citation | Mallick, Rahul Bhowmik, Prasenjit Duttaroy, Asim Kanti . Targeting fatty acid uptake and metabolism in cancer cells: A promising strategy for cancer treatment. Biomedicine & Pharmacotherapy. 2023, 167 | |
dc.identifier.uri | http://hdl.handle.net/10852/108362 | |
dc.description.abstract | Despite scientific development, cancer is still a fatal disease. The development of cancer is thought to be significantly influenced by fatty acids. Several mechanisms that control fatty acid absorption and metabolism are reported to be altered in cancer cells to support their survival. Cancer cells can use de novo synthesis or uptake of extracellular fatty acid if one method is restricted. This factor makes it more difficult to target one pathway while failing to treat the disease properly. Side effects may also arise if several inhibitors simultaneously target many targets. If a viable inhibitor could work on several routes, the number of negative effects might be reduced. Comparative investigations against cell viability have found several potent natural and manmade substances. In this review, we discuss the complex roles that fatty acids play in the development of tumors and the progression of cancer, newly discovered and potentially effective natural and synthetic compounds that block the uptake and metabolism of fatty acids, the adverse side effects that can occur when multiple inhibitors are used to treat cancer, and emerging therapeutic approaches. | |
dc.language | EN | |
dc.rights | Attribution 4.0 International | |
dc.rights.uri | https://creativecommons.org/licenses/by/4.0/ | |
dc.title | Targeting fatty acid uptake and metabolism in cancer cells: A promising strategy for cancer treatment | |
dc.title.alternative | ENEngelskEnglishTargeting fatty acid uptake and metabolism in cancer cells: A promising strategy for cancer treatment | |
dc.type | Journal article | |
dc.creator.author | Mallick, Rahul | |
dc.creator.author | Bhowmik, Prasenjit | |
dc.creator.author | Duttaroy, Asim Kanti | |
cristin.unitcode | 185,51,13,20 | |
cristin.unitname | Seksjon for klinisk ernæring | |
cristin.ispublished | true | |
cristin.fulltext | original | |
cristin.qualitycode | 1 | |
dc.identifier.cristin | 2195081 | |
dc.identifier.bibliographiccitation | info:ofi/fmt:kev:mtx:ctx&ctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=Biomedicine & Pharmacotherapy&rft.volume=167&rft.spage=&rft.date=2023 | |
dc.identifier.jtitle | Biomedicine & Pharmacotherapy | |
dc.identifier.volume | 167 | |
dc.identifier.pagecount | 20 | |
dc.identifier.doi | https://doi.org/10.1016/j.biopha.2023.115591 | |
dc.type.document | Tidsskriftartikkel | |
dc.type.peerreviewed | Peer reviewed | |
dc.source.issn | 0753-3322 | |
dc.type.version | PublishedVersion | |
cristin.articleid | 115591 | |